Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Melanoma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hematologic Neoplasms 1

Interventions

tipifarnib 1ruxolitinib 1ripretinib 1peginterferon alfa-2a 1cobimetinib 1cc-486 1bemcentinib 1avelumab 1Vemurafenib 1Standard of Care 1Quality of Life 1Practice Guidelines as Topic 1Pentetic Acid 1Pemetrexed 1Patient Reported Outcome Measures 1Palliative Care 1PLX8394 1Nurse Clinicians 1Molecular Diagnostic Techniques 1Minocycline 1Ipilimumab 1Interferon alpha-2 1Injections 1In Situ Hybridization, Fluorescence 1Immunotherapy 1Imatinib Mesylate 1Heparin 1Fentanyl 1Drug Therapy 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Melanoma × Nurse Clinicians × Myeloid × Clear all
NCT00179764 2019-08-30

Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])

Ann & Robert H Lurie Children's Hospital of Chicago

Phase NA Completed
68 enrolled
DermatologicLymphoidMyeloidOther hematologic neoplasm

Melanoma, Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡